Article Details

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Average Rating of “Buy” from Analysts

Retrieved on: 2020-01-23 18:18:45

Tags for this article:

Click the tags to see associated articles and topics

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Average Rating of “Buy” from Analysts. View article details on hiswai:

Excerpt

<div><b>Acadian Asset Management</b> LLC grew its position in shares of Rigel Pharmaceuticals by 548.3% in the 2nd quarter. <b>Acadian Asset Management</b> LLC ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up